• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

44.43 -1.16 (-2.54%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 327,427
Open 45.49
Bid (Size) 41.05 (500)
Ask (Size) 51.98 (100)
Prev. Close 45.59
Today's Range 43.32 - 46.67
52wk Range 12.56 - 58.90
Shares Outstanding 54,902,942
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
October 14, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 09, 2026
From Pulse Biosciences, Inc.
Via Business Wire

Performance

52-Week Range 24.6% below 52-week high
44.43
12.5652W Low 58.9052W High
1 Week 17.7% below 1-week high
43.321W Low 53.981W High

Pulse Biosciences, Inc - Common Stock (PLSE) traded between $12.56 and $58.90 over the past 52 weeks and last traded at $44.43, 24.6% below its 52-week high. Over the past week it ranged between $43.32 and $53.98.

Past 12 Months
-15.3%
-12.2%
+53.4%
+87.2%
+231.8%
+153.0%
1W -$8.02
1M -$6.18
3M +$15.47
6M +$20.70
YTD +$31.04
1Y +$26.87

PLSE was +153.0% over the past year, +87.2% over six months, +231.8% year to date, -15.3% in the last week.

12 Months vs Market
PLSE
+153.0%
DIA
+12.4%
SPY
+14.9%
QQQ
+17.5%
IWM
+11.1%

Over the past 12 months PLSE returned +153.0% versus DIA (Dow) +12.4%, SPY (S&P 500) +14.9%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +11.1%.

Volume & Liquidity 0.63× 3-mo avg
Today 327,427 3-mo avg 519.7K
1W
416.6K
1M
480.5K
3M
519.7K
6M
430.5K
YTD
391.4K
1Y
345.0K

PLSE most recently traded 327,427 shares against a 3-month average daily volume of 519.7K.

More News

Read More
News headline image
Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026
October 08, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment
October 07, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules
September 15, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Why Pulse Biosciences Stock Popped Today ↗
September 09, 2026
Via The Motley Fool
News headline image
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 04, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Eyes AFib Breakthrough With Nanosecond PFA Platform ↗
August 16, 2026
Via MarketBeat
Topics Intellectual Property
News headline image
Pulse Biosciences (PLSE) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
Via The Motley Fool
Topics Earnings
News headline image
Pulse Biosciences Q2 Earnings Call Highlights ↗
August 07, 2026
Via MarketBeat
Topics Earnings Intellectual Property
News headline image
Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results
August 06, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference
July 30, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study
July 29, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026
July 21, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 15, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
June 10, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
May 27, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors. ↗
May 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million
May 12, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences Q1 Earnings Call Highlights ↗
May 08, 2026
Via MarketBeat
Topics Earnings
News headline image
PLSE Q1 2026 Earnings Transcript ↗
May 08, 2026
Via The Motley Fool
News headline image
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
May 08, 2026
From Pulse Biosciences, Inc.
Via Business Wire
News headline image
Pulse Biosciences (PLSE) Q1 2025 Earnings Transcript ↗
May 04, 2026
Via The Motley Fool
News headline image
PLSE Q4 2025 Earnings Transcript ↗
May 04, 2026
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is Pulse Biosciences, Inc - Common Stock publicly traded?
Yes, Pulse Biosciences, Inc - Common Stock is publicly traded.
What exchange does Pulse Biosciences, Inc - Common Stock trade on?
Pulse Biosciences, Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pulse Biosciences, Inc - Common Stock?
The ticker symbol for Pulse Biosciences, Inc - Common Stock is PLSE on the Nasdaq Stock Market
What is the current price of Pulse Biosciences, Inc - Common Stock?
The current price of Pulse Biosciences, Inc - Common Stock is 44.43
When was Pulse Biosciences, Inc - Common Stock last traded?
The last trade of Pulse Biosciences, Inc - Common Stock was at 10/16/26 04:00 PM ET
What is the market capitalization of Pulse Biosciences, Inc - Common Stock?
The market capitalization of Pulse Biosciences, Inc - Common Stock is 2.44B
How many shares of Pulse Biosciences, Inc - Common Stock are outstanding?
Pulse Biosciences, Inc - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap